Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect Study.
van den Bos W, Jurhill RR, de Bruin DM, Savci-Heijink CD, Postema AW, Wagstaff PG, Muller BG, Varkarakis IM, Skolarikos A, Zondervan PJ, Laguna Pes MP, de Reijke TM, de la Rosette JJ.
van den Bos W, et al.
J Urol. 2016 Aug;196(2):552-9. doi: 10.1016/j.juro.2016.02.2977. Epub 2016 Mar 19.
J Urol. 2016.
PMID: 27004693
Clinical Trial.